GOLO Diet Pills’ Benefits Are Falsely Advertised, Class Action Lawsuit Alleges

Delaware-based diet pill company GOLO mislabeled its products and falsely advertised their weight loss and health benefits, a new lawsuit alleges.

Lead plaintiff Vincenzza Bubak filed the nationwide class action lawsuit this week accusing GOLO, LLC of engaging in prominent and systematic mislabeling and false advertising of its Release supplement that “could lead to substantial societal harm.”

Bubak bought the GOLO diet pills online in December 2020, based on claims made on the company’s website that the Release supplement would aid weight loss and provide other health benefits, says the class action lawsuit.

The pills, sold nationwide, are advertised as “the natural solution to insulin resistance,” which GOLO says is a major obstacle to losing weight.

Bubak says the pills did not work as advertised and she requested a refund from the company. Bubak says she had to cover the associated shipping and handling costs.

Bubak alleges that the company unlawfully implied the diet pills could mitigate or prevent disease. She also claims that the company gave inadequate directions for use and misleadingly said the pills were clinically proven to boost its sales.

“The Product is offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners; therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes,” the lawsuit states.

For a claim to be considered scientifically and clinically proven, the lawsuit contends, it must be widely accepted in its applicable field, have overwhelming evidence supporting it and there must be a consensus in the scientific community agreeing with the representations. The lawsuit alleges that GOLO said the studies its claims were based on relied on “pilot studies” commissioned by the company that were not peer-reviewed or part of legitimate scientific publications.

The lawsuit estimates that thousands of customers have been affected by GOLO’s alleged fraudulent behavior.

For the California subclass, Bubak is suing the company under California’s unfair competition law, false advertising law, and legal remedies act. For national and California-based consumers, Bubak is suing under the breach of warranties and breach of implied warranty of merchantability.

Bubak is seeking class action certification, damages, restitution, audit or previous complaints, interest, legal fees, and a jury trial.

This isn’t the first time a company has faced a class action lawsuit over diet pills. In February 2020, the U.S. Food and Drug Administration (FDA) announced the voluntary recall of Belviq and Belviq XR, weight loss drugs manufactured by Eisai Inc. The Belviq recall was prompted by a safety clinical trial showing the drug may be associated with an increased risk of cancer. Find out if you qualify to join the lawsuit here.

Meanwhile, plaintiffs in the Lipzozene weight loss pill class action lawsuit have started to receive checks worth up to $60.

Have you purchased GOLO diet pills? Did they work as advertised for you? Tell us about your experience in the comment section below!

The plaintiff is represented by Trenton R. Kashima and Kevin J. Stoops of Sommers Schwartz, P.C., and Nick Suciu III of Barbat Mansour Suciu & Tomina PLLC.

The GOLO Diet Pill Class Action Lawsuit is Bubak v. GOLO, LCC, Case No. 1:21-cv-00492-DAD-EPG, in the U.S. District Court for the Eastern District of California.

Read About More Class Action Lawsuits & Class Action Settlements:

• Move Free Supplement Maker Agrees to $53M False Advertising Class Action Settlement
• MedFit Owner Gets Jail Time, $335K Fine Over Steroid-Like Supplements
• Clothing & Restaurant Coupon Text Lawsuit Investigation
• Do You Qualify: Walmart Spring Valley Glucosamine Supplement Class Action Lawsuit Investigation